Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade. (Q50908445)
Jump to navigation
Jump to search
scientific article published in November 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade. |
scientific article published in November 2015 |
Statements
Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade. (English)
1 reference
Philipp Müller
Matthias Kreuzaler
Katharina Glatz
Spasenija Savic
Nadia Harbeck
Ulrike Nitz
Oleg Gluz
Michael von Bergwelt-Baildon
Hans Kreipe
Matthias Christgen
1 November 2015
1 reference